#clinical-trial-design

[ follow ]
#ai-in-drug-discovery #venture-funding #biopharma #end-to-end-automation #hepatitis-b #vaccine-ethics
Venture
fromfortune.com
1 day ago

Exclusive: Ex-Palantir AI execs raise $12 million seed round for Perceptic, a startup automating drug discovery

Perceptic is launching an end-to-end AI platform for drug discovery and clinical trial design, raising $12 million seed funding led by Accel.
Public health
fromArs Technica
3 months ago

WHO slams US-funded newborn vaccine trial as "unethical"

Withholding the proven hepatitis B vaccine birth dose from newborns for a trial is unethical and exposes them to serious, potentially irreversible harm.
[ Load more ]